{"id":148176,"date":"2021-10-11T19:02:00","date_gmt":"2021-10-11T19:02:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2929102"},"modified":"2021-10-11T19:02:00","modified_gmt":"2021-10-11T19:02:00","slug":"antihypertensive-drugs-market-size-share-trends-segmentation-and-forecast-2021-2026","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/10\/11\/antihypertensive-drugs-market-size-share-trends-segmentation-and-forecast-2021-2026\/","title":{"rendered":"Antihypertensive Drugs Market Size, Share, Trends, Segmentation and Forecast 2021-2026"},"content":{"rendered":"

\"3485<\/p>\n

As per the latest report by IMARC Group, titled \u201cAntihypertensive Drugs<\/strong>\u00a0<\/a><\/span>Market<\/a><\/span>: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026\u201d,\u00a0<\/strong>the\u00a0global antihypertensive drugs market exhibited XX growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026. Antihypertensive drugs refer to therapeutic medications used to prevent, treat, and control hypertension and high blood pressure disorders. Some of the commonly used antihypertensive drugs include diuretics, calcium channel blockers, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, etc. These drugs help in removing excess fluids and salts from the body and relax and widen blood vessels. They also slow down the heartbeat to maintain healthy systolic blood pressure. Antihypertensive drugs can be administered orally or through intravenous injections and find extensive applications in hospitals, clinics, rehabilitation centers, ambulatory surgical centers, etc.<\/p>\n

We are regularly tracking the direct effect of\u00a0<\/strong>COVID-19<\/u><\/strong><\/em>\u00a0on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.<\/strong><\/p>\n

Request Free Sample Report:\u00a0<\/strong>https:\/\/www.imarcgroup.com\/antihypertensive-drugs-market\/requestsample<\/a><\/p>\n

Antihypertensive Drugs Market Trends:<\/strong><\/p>\n

The rising prevalence of hypertension and cardiovascular disorders across the globe is primarily driving the market for hypertensive drugs. This can be attributed to increasingly sedentary lifestyles and unhealthy dietary patterns of the population. Moreover, the expanding geriatric population, who are more susceptible to such conditions, is catalyzing the market growth. In line with this, the growing need for the timely prevention and treatment of hypertension, coupled with the widespread adoption of combination therapies using multiple drugs, is further escalating the product demand. Additionally, the development of imidazolines, monatepil, and neutral endopeptidase inhibitors that prevent the metabolism of vasoactive peptides is anticipated to propel the market growth over the forecasted period.<\/p>\n

Explore Full Report with TOC & List of Figure:\u00a0<\/strong>https:\/\/www.imarcgroup.com\/antihypertensive-drugs-market<\/a><\/p>\n

Key Market Segmentation:<\/strong><\/p>\n

Competitive Landscape:<\/strong><\/p>\n

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.<\/p>\n

Some of these key players include:<\/strong><\/p>\n